Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-04-12

Clinical Trial Update: The Effect of Insoluble Yeast Beta-glucan Intake on Pre-diabetic Patients [NA]

View source ↗

Summary

An update on a clinical trial assessing the effect of insoluble yeast beta-glucan intake in individuals with prediabetes. The current status is not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insoluble Yeast Beta-glucan (beta-glucan (yeast-derived))

Snippet

Sponsor: Huazhong University of Science and Technology | Conditions: Pre-diabetic | NA | Status: UNKNOWN